Literature DB >> 6577437

Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin.

M J Griffith.   

Abstract

Three different heparin-catalyzed inhibitor/protease reactions were studied: antithrombin III/thrombin, heparin cofactor II/thrombin, antithrombin III/factor Xa. The three reactions were saturable with respect to both inhibitor and protease. The initial reaction velocity, for each reaction, could be described by the general rate equation for a random-order bireactant enzyme-catalyzed reaction. The kinetic parameters for the heparin-catalyzed antithrombin III/thrombin and antithrombin III/factor Xa reactions differed in terms of apparent maximum velocity (Vmax) and apparent heparin-protease dissociation constant values. The apparent heparin-antithrombin III dissociation constant values were the same for both reactions. The kinetic parameters for the heparin-catalyzed antithrombin III/thrombin and heparin cofactor II/thrombin reactions differed in terms of apparent Vmax and apparent heparin-inhibitor dissociation constant values. The apparent heparin-thrombin dissociation constant values were the same for both reactions. The results are consistent with a general mechanism of action of heparin for the three reactions that, in its simplest form, requires only that both protease and inhibitor bind to heparin for catalysis to occur.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6577437      PMCID: PMC384277          DOI: 10.1073/pnas.80.18.5460

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Studies on the mechanism of the rate-enhancing effect of heparin on the thrombin-antithrombin III reaction.

Authors:  E Holmer; G Söderström; L O Andersson
Journal:  Eur J Biochem       Date:  1979-01-02

2.  Identification of two distinct heparin cofactors in human plasma. Separation and partial purification.

Authors:  G F Briginshaw; J N Shanberge
Journal:  Arch Biochem Biophys       Date:  1974-04-02       Impact factor: 4.013

3.  The purification and mechanism of action of human antithrombin-heparin cofactor.

Authors:  R D Rosenberg; P S Damus
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

4.  Identification of two distinct heparin cofactors in human plasma. II. Inhibition of thrombin and activated factor X.

Authors:  G F Briginshaw; J N Shanberge
Journal:  Thromb Res       Date:  1974-03       Impact factor: 3.944

5.  Highly purified antithrombin 3 with heparin cofactor activity prepared by disc electrophoresis.

Authors:  U Abildgaard
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

Review 6.  Chemistry of the hemostatic mechanism and its relationship to the action of heparin.

Authors:  R D Rosenberg
Journal:  Fed Proc       Date:  1977-01

7.  The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.

Authors:  R E Jordan; G M Oosta; W T Gardner; R D Rosenberg
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

8.  Heparin cofactor activities in a family with hereditary antithrombin III deficiency: evidence for a second heparin cofactor in human plasma.

Authors:  M J Griffith; T Carraway; G C White; F A Dombrose
Journal:  Blood       Date:  1983-01       Impact factor: 22.113

9.  Effect of heparin modification on its activity in enhancing the inhibition of thrombin by antithrombin III.

Authors:  I Danishefsky; M Ahrens; S Klein
Journal:  Biochim Biophys Acta       Date:  1977-06-23

10.  A catalytic role for heparin. Evidence for a ternary complex of heparin cofactor thrombin and heparin.

Authors:  M W Pomerantz; W G Owen
Journal:  Biochim Biophys Acta       Date:  1978-07-21
View more
  8 in total

1.  Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.

Authors:  B Bray; D A Lane; J M Freyssinet; G Pejler; U Lindahl
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

2.  Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.

Authors:  M F Scully; V Ellis; N Seno; V V Kakkar
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

3.  Inhibition of chymotrypsin by heparin cofactor II.

Authors:  F C Church; C M Noyes; M J Griffith
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

Review 4.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

5.  Heparinoids activate a protease, secreted by mucosa and tumors, via tethering supplemented by allostery.

Authors:  Yan G Fulcher; Raghavendar Reddy Sanganna Gari; Nathan C Frey; Fuming Zhang; Robert J Linhardt; Gavin M King; Steven R Van Doren
Journal:  ACS Chem Biol       Date:  2014-02-10       Impact factor: 5.100

6.  Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.

Authors:  H C Whinna; F C Church
Journal:  J Protein Chem       Date:  1993-12

7.  Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.

Authors:  M F Scully; V Ellis; N Shah; V Kakkar
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

Review 8.  Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.

Authors:  M Verstraete
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.